Stratigos, A.; Sekulic, A.; Peris, K.; Bechter, O.; Kaatz, M.; Lewis, K.; Basset-Segiun, N.; Chang, A. L.; Dalle, S.; Orland, A. F.; Licitra, L.; Robert, C.; Ulrich, C.; Hauschild, A.; Migden, M.; Dummer, R.; Li, S.; Mohan, K.; Coates, E.; Jankovic, V.; Flaschi, N.; Okoye, E.; Bassukas, I.; Loquai, C.; De Giorgi, V.; Eroglu, Z.; Gutzmer, R.; Ulrich, J.; Puig, S.; Seebach, F.; Thurston, G.; Lowy, I.; Bowler, T.; Fury, M. Primary Analysis of Phase 2 Results for Cemiplimab in Patients (pts) With Locally Advanced Basal Cell Carcinoma (laBCC) Who Progress on or Are Intolerant to Hedgehog Inhibitors (HHIs). J of Skin 2021, 5, s4.